A Nuclear Magnetic Resonance Spectroscopy Method in Characterization of Blood Metabolomics for Alzheimer’s Disease

A Nuclear Magnetic Resonance Spectroscopy Method in Characterization of Blood Metabolomics for Alzheimer’s Disease

There is currently a crucial need for improved diagnostic techniques and targeted treatment methods for Alzheimer’s disease (AD), a disease which impacts millions of elderly individuals each year. Metabolomic analysis has been proposed as a potential methodology to better investigate and understand...

Full description

Bibliographic Details
Main Authors: Arnold, S.E (Author), Cheng, L.L (Author), Hyman, B.T (Author), Kivisäkk, P. (Author), Muti, I.H (Author), Weng, J. (Author), Zhong, A.B (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
aged
Alzheimer disease
Alzheimer’s disease
Article
Blood plasma
clinical article
Clinical Dementia Rating
cognition
cohort analysis
controlled study
degenerative disease
docosahexaenoic acid
Expanded Disability Status Scale
female
gas chromatography
glucose
glutamic acid
glycolysis
human
human tissue
lactic acid
male
metabolomics
Metabolomics
Mini Mental State Examination
neurofibrillary tangle
nuclear magnetic resonance spectroscopy
Nuclear magnetic resonance spectroscopy
Parkinson disease
prevalence
proton nuclear magnetic resonance
quality control
risk factor
time of flight mass spectrometry
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items